Welcome to the GSK Oncology Medical Affairs exhibit page.  GSK is focused on maximizing patient survival through transformational medicines.  Our goal is to achieve a sustainable flow of new treatments based on a diversified portfolio of investigational medicines utilizing modalities such as small molecules, antibodies, antibody drug conjugates and cells, either alone or in combination. For more information please visit: MiQuest Oncology | GSK US Medical Affairs